Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia
Clinical trial NCT00039130 · COMPLETED
Trial details
- NCT number
- NCT00039130
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-05-01
- Primary completion
- 2010-09-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.